Reuters logo
BRIEF-Biotec Pharmacon Q3 EBITDA loss widens to NOK 7.3 mln
October 19, 2017 / 5:07 AM / a month ago

BRIEF-Biotec Pharmacon Q3 EBITDA loss widens to NOK 7.3 mln

Oct 19 (Reuters) - BIOTEC PHARMACON ASA

* Q3 REVENUE NOK ‍14.4​ MILLION VERSUS NOK 21.1 MILLION YEAR AGO

* Q3 EBITDA LOSS NOK ‍7.3​ MILLION VERSUS LOSS NOK 5.9 MILLION YEAR AGO Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below